Advicenne S.A.
Paris Stock Exchange ALDVI.PA
Advicenne S.A. Total Assets for the year ending December 31, 2023: USD 13.69 M
Advicenne S.A. Total Assets is USD 13.69 M for the year ending December 31, 2023, a -10.24% change year over year. Total assets are the total value of all assets owned by a company, representing its resources.
-
Advicenne S.A. Total Assets for the year ending December 31, 2022 was USD 15.26 M, a -29.02% change year over year.
-
Advicenne S.A. Total Assets for the year ending December 31, 2021 was USD 21.49 M, a -26.70% change year over year.
-
Advicenne S.A. Total Assets for the year ending December 31, 2020 was USD 29.32 M, a 14.00% change year over year.
-
Advicenne S.A. Total Assets for the year ending December 31, 2019 was USD 25.72 M, a -32.25% change year over year.
Key data
| Date | Total Assets | Current Liabilities | Total Non-Current Liabilities | Shareholders' Equity |
|---|
Market news
Loading...
Paris Stock Exchange: ALDVI.PA
| CEO | Mr. Didier Laurens |
| IPO Date | Dec. 6, 2017 |
| Location | France |
| Headquarters | 3ème étage 262 |
| Employees | 21 |
| Sector | Health Care |
| Industries | |
Description
Advicenne S.A., a specialty pharmaceutical company, develops and commercializes treatments for nephrology. Its lead product candidate is Sibnayal for the treatment of distal renal tubular acidosis, as well as for the treatment of cystinuria. Advicenne S.A. was founded in 2007 and is headquartered in Paris, France.
Key trends
Past 5 years
StockViz Staff
January 15, 2025
Any question? Send us an email